1. Home
  2. TECX vs SKYH Comparison

TECX vs SKYH Comparison

Compare TECX & SKYH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Tectonic Therapeutic Inc.

TECX

Tectonic Therapeutic Inc.

HOLD

Current Price

$29.47

Market Cap

393.0M

Sector

N/A

ML Signal

HOLD

Logo Sky Harbour Group Corporation

SKYH

Sky Harbour Group Corporation

HOLD

Current Price

$9.48

Market Cap

324.6M

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
TECX
SKYH
Founded
2019
2017
Country
United States
United States
Employees
51
N/A
Industry
Military/Government/Technical
Sector
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
393.0M
324.6M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
TECX
SKYH
Price
$29.47
$9.48
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
5
3
Target Price
$80.40
$13.83
AVG Volume (30 Days)
323.2K
109.2K
Earning Date
05-07-2026
03-19-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$95.29
Revenue Next Year
N/A
$69.22
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$13.70
$8.22
52 Week High
$35.99
$14.20

Technical Indicators

Market Signals
Indicator
TECX
SKYH
Relative Strength Index (RSI) 54.30 55.25
Support Level $16.83 $8.42
Resistance Level $35.99 $9.64
Average True Range (ATR) 2.85 0.39
MACD -0.27 0.05
Stochastic Oscillator 55.28 48.65

Price Performance

Historical Comparison
TECX
SKYH

About TECX Tectonic Therapeutic Inc.

Tectonic Therapeutic Inc is a biotechnology company focused on the discovery and development of therapeutic proteins and antibodies that modulate the activity of GPCRs. Its technology platform called GEODe, Tectonic is focused on developing biologic medicines that overcome the existing challenges of GPCR-targeted drug discovery to modify the course of disease. Company focus on areas of important unmet medical need, often where therapeutic options are poor or nonexistent, and where new medicines have the potential to improve patient quality of life or extend duration of life. Pipeline includes TX000045, Group 2 PH, TX2100: GPCR Antagonist for Hereditary Hemorrhagic Telangiectasia (HHT), Fibrosis.

About SKYH Sky Harbour Group Corporation

Sky Harbour Group Corp is an aviation infrastructure company building a nationwide network of Home-based solutions for business aircraft. The company develops, leases, and manages business aviation hangars across the United States based on its proprietary targeting and acquisition model, targeting airfields with hangar supply and demand imbalances in the markets. Its hangar campuses feature exclusive private hangars and a full suite of dedicated services specifically designed for home-based aircraft.

Share on Social Networks: